Samsung Rasagiline Tablet 1.0 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be used by individuals allergic to the active ingredient or other components. Do not administer this drug if you are currently taking or have stopped taking other MAO inhibitors within the last two weeks. It should not be used if you are currently taking or have stopped taking the analgesic pethidine within the last two weeks. Patients taking medications such as tramadol or dextromethorphan should also avoid using this medication due to the risk of serious side effects from interactions. Patients with moderate to severe liver impairment should not take this medication. This medication can cause various side effects, with common side effects including headache, dizziness, depression, hallucinations, dermatitis, and musculoskeletal pain. Particularly, Parkinson's patients should be cautious about the potential for movement disorders or hypotension. During treatment, obsessive behavior and impulse control disorders may occur, so both the patient and caregiver should closely monitor for these symptoms. Additionally, this medication can cause drowsiness or sudden sleep, necessitating caution when driving or operating machinery. Due to numerous interactions with other drugs, especially with MAO inhibitors, antidepressants, sympathomimetics, and certain analgesics, it is crucial to consult a healthcare professional before use. Pregnant or breastfeeding women need to be cautious when taking this medication, and it is advisable not to use it in children as safety has not been established. In case of overdose, serious side effects may occur, so adherence to the prescribed dosage is essential. If an overdose is suspected, seek medical attention immediately. Store this medication out of reach of children and maintain storage temperatures between 1 and 25 degrees Celsius. Avoid transferring it to different containers as this can compromise quality.

• Influenza
• skin cancer
• leukopenia
• allergies
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best kept in a cool place between 1 and 25 degrees Celsius. Avoid direct sunlight and high temperatures, and store it in a safe place to maintain the medication's effectiveness.

Appearance

Flat round tablets with white or almost white edges

Package unit

30 tablets/Blister [(10 tablets/Blister x 3)]